CURATIVE BIOTECHNOLOGY, INC.

Insiders Curative Biotechnology, Inc.

Equities

CUBT

US23128N1081

End-of-day quote OTC Markets Other stock markets 03:30:00 06/06/2024 am IST			5-day change	1st Jan Change
0.0182 ^USD	-4.21%		+11.66%	-14.55%

06/05	Curative Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million.	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Curative Biotechnology Inc. Adds Biotech Veteran Lawrence S. Zaslow to Board of Directors	16/22/16	CI
Curative Biotechnology, Inc. Appoints Cary Sucoff to Board of Directors	12/22/12	CI
Curative Biotechnology, Inc. Appoints Dr. Catherine Sohn as Special Advisor to Board and CEO	12/21/12	CI
Curative Biotechnology, Inc. Announces Addition of Dr. Nicholas Boulis to Scientific and Clinical Advisory Board	02/21/02	CI
Curative Biotechnology, Inc. Announces Additions to Scientific and Clinical Advisory Board	29/21/29	CI
Connectyx Technologies Holdings Group, Inc. Announces Management Changes	11/21/11	CI
Connectyx Technologies Holdings Group, Inc. Appoints I Richard Garr as Chief Executive Officer	11/21/11	CI
Connectyx Announces Appointment of Michael K. Fish to Board of Directors	25/20/25	CI
Connectyx Appoints I. Richard Garr, Esq. to Company’S Scientific Advisory Board	19/20/19	CI
Connectyx Technologies Holdings Group, Inc. Announces Board Changes	08/20/08	CI
Connectyx Technologies Holdings Group Announces Management Changes	06/20/06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer